PTH and chronic kidney disease: FGF23 and PTH were increased in CKD and diosmin suppressed both. CKD reduced bone mass and deteriorated the microarchitecture of trabecular bones, and diosmin maintained both at control levels. Bone formation and strength were impaired in CKD and diosmin maintained these levels at control levels.